about
Personal genomics services: whose genomes?Predictive and prognostic molecular markers for cancer medicineMachine learning and systems genomics approaches for multi-omics data.Pharmacogenomics, evidence, and the role of payers.US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society.Reducing obesity: motivating action while not blaming the victim.Germs, genomics and global public health: How can advances in genomic sciences be integrated into public health in the developing world to deal with infectious diseases?Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiersConsumers' use of web-based information and their decisions about multiplex genetic susceptibility testingGenetic Stalking and Voyeurism: A New Challenge to Privacy.Quantification of population benefit in evaluation of biomarkers: practical implications for disease detection and prevention.The promise and reality of pharmacogenetics in psychiatryDirect-to-consumer personalized genomic testing.Participation in genetic testing research varies by social group.Genetic Testing and Type 2 Diabetes Risk Awareness.Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions.Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations.Patients' understanding of and responses to multiplex genetic susceptibility test resultsThe challenges for molecular nutrition research 1: linking genotype to healthy nutrition.Putting science over supposition in the arena of personalized genomics.The regulation of direct-to-consumer genetic testsRegulatory agency consideration of pharmacogenomics.Pharmacogenetic considerations in the treatment of psychiatric disorders.Genome technologies and personalized dental medicine.Systems biology technologies enable personalized traditional Chinese medicine: a systematic review.Fruit flies as a powerful model to drive or validate pain genomics efforts.Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.Genetic self knowledge and the future of epidemiologic confounding.Towards the systematic development of medical networking technology.Is there a niche for DNA microarrays in molecular diagnostics?Tiny medicine: nanomaterial-based biosensors.Canadian health care professionals' knowledge, attitudes and perceptions of nutritional genomics.What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?Evaluating the utility of personal genomic information.The future of psychiatric pharmacogenomics.The impact of pharmacokinetic gene profiles across human cancers.Improving the quality of 'personalized medicine' research and practice: through an ethical lensStem Cells and Genetic Testing: The Gap Between Science and Society WidensDTC Marketing of Genetic Tests: The Perfect Storm
P2860
Q24600731-ECEB2146-3C73-4B44-B8B9-E01D3B82DBFBQ28743108-A6DA7A2F-706C-4F3B-B7DF-3F216440BFD0Q31157242-ACEE43D0-07B2-4042-908E-5748B950C42CQ33721099-B1612748-CC48-4E5B-84FF-BC96E465A0FCQ33863191-3889BEAA-B5E5-498D-A9CE-66E7928D75D8Q33887842-47AD1E8E-0BD2-49F7-A326-F609587F964EQ33901616-F1407C9C-E8D3-4BA8-853B-DA226877EFBDQ33947336-12257C2D-ABFA-4A69-A87C-71E906DD3EDAQ34206524-F6B610DF-61E8-4001-BADF-8B9946A5189DQ34554140-885789BA-FE82-4894-A3E1-6A46CC02982FQ35112414-80841F00-4154-4D37-B7C7-3A0CEEF7B840Q35226451-7A7A77D2-180A-4EAB-882E-2C72830CD02DQ35230171-CB91A260-23FB-496A-83E9-40C0E7A12241Q35546414-F24F862E-8E53-4A3B-8F65-5DD805FA8AFCQ35761568-52A120CB-3864-4426-92C4-F0580175C6BBQ35926344-010BCE72-9643-4FF0-B002-B81B0003CCB9Q35946640-60ADD6B3-795A-48AC-8F58-078A1F62C834Q36157791-973A95BD-6E48-4706-8F9D-0B90E968A235Q36772383-157E852F-9898-4C6E-8093-4C01CE795CF3Q36865829-792F0F68-73A2-44FF-AB23-3C0EC262149DQ37168293-442C9499-1C5C-45ED-AA0C-DD04257DE6C6Q37292136-6B87E1EF-062B-4B2C-B21E-B12B8DE01B49Q37681573-8389FC29-6090-4D93-900B-72FAE57C0C69Q37963085-C3E372D1-9148-4853-BD6B-17F3E3191E12Q38066235-52F641C0-42AF-486A-BB2F-B74D15B9D93DQ38162868-23B20859-4F21-4690-942D-0C659B7ACE3EQ39844006-61553CFE-91E1-41AB-8710-BFF407ACA372Q39849131-D84E553B-BF34-4CB5-AE81-ED93F4BE4610Q39945669-A90846FF-B2DD-4A96-9E23-9B1852C83F20Q39955702-513A9343-6C5B-4ABE-AA45-7176ECBDD977Q40014039-9CA78370-DA84-4C34-8464-9841A4BE5FEEQ42664169-7EA14D9C-15AB-485E-A123-ED2539AEFF16Q46639562-E3ADBE28-F797-4038-ADBF-09026023AE79Q47593006-3B99234C-C20D-4DF9-AE4B-E2F2ED570F69Q51692060-CF80CBA5-0BB3-47B7-8110-401A690B36EBQ55294975-A9F8AAF2-EF0E-46B8-A05A-D39ABE4B6B14Q56523668-EAEA80C6-C8AD-4D6A-B472-63DFEAA46C15Q57989059-F093BF0D-470B-49AB-8F71-EADBDD86963FQ57989839-A906B49B-F827-475D-A769-76E3694B9FCF
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Public health. A case study of personalized medicine.
@en
Public health. A case study of personalized medicine.
@nl
type
label
Public health. A case study of personalized medicine.
@en
Public health. A case study of personalized medicine.
@nl
prefLabel
Public health. A case study of personalized medicine.
@en
Public health. A case study of personalized medicine.
@nl
P356
P1433
P1476
Public health. A case study of personalized medicine
@en
P2093
P356
10.1126/SCIENCE.1156604
P407
P577
2008-04-01T00:00:00Z